BCX-14

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameBCX-14
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionPurine nucleoside phosphorylase inhibitorsImmunosuppressants
TargetsPurine nucleoside phosphorylase
Therapy Area/IndicationsRejection of organ transplantationDiabetes MellitusLupus Erythematosus, Systemic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiocryst Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiocryst Pharmaceuticals IncNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationDiabetes MellitusLupus Erythematosus, Systemic +[4] 

Other Information

ATC CodeN/A
Related LinksN/A